Wendel Eva-Maria, Tibussek Daniel, Barisic Nina, Bertolini Annikki, Panzer Andreas, Chang Petrus, Geis Tobias, Knierim Ellen, Nikolaus Marc, Nosadini Margherita, Sartori Stefano, Schoene-Bake Jan-Christoph, Yilmaz Deniz, Reindl Markus, Pakeerathan Thivya, Ayzenberg Ilya, Rostásy Kevin
Department of Pediatric Neurology, Department of Pediatrics, Olgahospital, Stuttgart, Germany.
Center for Pediatric and Teenage Health Care, Division of Neuropediatrics, Sankt Augustin, Germany.
Mult Scler Relat Disord. 2025 Jan;93:106205. doi: 10.1016/j.msard.2024.106205. Epub 2024 Dec 15.
Fulminant idiopathic intracranial hypertension (IIH) is characterized by headache, rapid decrease of vision and elevated CSF-opening pressure.
To delineate a subgroup of MOGAD mimicking fulminant IIH.
In this case series children with MOGAD with vision loss, optic disc swelling and elevated CSF opening pressure, initially diagnosed with fulminant IIH, were included.
8 MOGAD patients (median age 12.5y, f:m = 7:1) with an initial diagnosis of fulminant IIH were included. Rapid bilateral visual loss and headache was present in all patients in addition to bilateral optic disc swelling and decreased visual acuity. In 2 patients cMRI showed prominent optic discs or an empty sella sign. In 7 patients the CSF opening pressure was markedly elevated. Patients were treated with Acetazolamide (n = 6), CSF external drainage (n = 2) or implantation of VP shunt (n = 1). Intravenous Methylprednisolone was administered in all patients because of worsening of symptoms, positive MOG-ab titers and/or new MRI white matter lesions. Visual recovery was good with residuals in 1/8 children. OCT revealed thickening of pRNFL in the acute stage in all patients with a rapid declining of pRNFL and retinal atrophy thereafter.
Children with bilateral MOGAD-ON presenting with loss of vision and elevated CSF opening pressure are at risk of being misdiagnosed as fulminant IIH. The role of elevated CSF opening pressure in MOGAD warrants further investigations. We recommend to include measurement of CSF opening pressure in the work up of neuroinflammatory diseases, in particular in patients with suspected MOGAD, to consider adapted pressure management.